chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Blood sodium decreased, COVID-19, Chest X-ray normal, Fall
Clinical narrative: Discharge Provider: Private DO Primary Care Provider at Discharge: Private DO  Admission Date: 3/8/2023 Discharge Date: 03/9/2023 PRESENTING PROBLEM: Debility [R53.81] Weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 75-year-old male with a past medical history significant for Alzheimer's dementia, seizure, hypertension, hyperlipidemia and diabetes who presented to the emergency department after a fall at home.  In the emergency department, vital signs were stable.  Lab work was obtained which revealed a sodium of 128. He was found to have COVID-19.  Chest x-ray with no acute cardiopulmonary disease.  Patient was admitted to the Internal Medicine Service for generalized weakness.  PT/OT evaluated patient recommended home with home health care.  The following day patient felt well. A 4ww was delivered to the hospital for patient to take home.  He was recommended follow up his primary care physician.  He was discharged home in stable condition
Age: 53.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Chills, Cough, Facial pain, Fatigue, Headache
Clinical narrative: I had severe headache, facial pain, a cough, sore throat, high fever, Chills with some sweating and extreme fatigue. 3/15/2023, felt like i had rebound COVID with all the same symptoms again.
Age: 53.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Hyperhidrosis, Malaise, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I had severe headache, facial pain, a cough, sore throat, high fever, Chills with some sweating and extreme fatigue. 3/15/2023, felt like i had rebound COVID with all the same symptoms again.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, Asthenia, Blood pressure decreased, COVID-19, Cough
Clinical narrative: I was feeling fatigued, had a sore throat, it made it's way up into my sinus cavities, I had a fever of 101F, I lost my taste for five days, On March 1, 2023, I choose to test with a home COVID-19 test it came back positive. I called my PCP who prescribed PAXLOVID, I started taking it immediately. It took me eight days to get over the worst of it. I tried going back to work but I could not make it through the day. My blood pressure would drop, I would need to sit and rest. That lasted another eight. I still have a bit of a cough left; my energy is returning.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Impaired work ability, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I was feeling fatigued, had a sore throat, it made it's way up into my sinus cavities, I had a fever of 101F, I lost my taste for five days, On March 1, 2023, I choose to test with a home COVID-19 test it came back positive. I called my PCP who prescribed PAXLOVID, I started taking it immediately. It took me eight days to get over the worst of it. I tried going back to work but I could not make it through the day. My blood pressure would drop, I would need to sit and rest. That lasted another eight. I still have a bit of a cough left; my energy is returning.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sinus disorder
Clinical narrative: I was feeling fatigued, had a sore throat, it made it's way up into my sinus cavities, I had a fever of 101F, I lost my taste for five days, On March 1, 2023, I choose to test with a home COVID-19 test it came back positive. I called my PCP who prescribed PAXLOVID, I started taking it immediately. It took me eight days to get over the worst of it. I tried going back to work but I could not make it through the day. My blood pressure would drop, I would need to sit and rest. That lasted another eight. I still have a bit of a cough left; my energy is returning.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Oropharyngeal pain, Pyrexia, Respiratory tract congestion
Clinical narrative: I did not have an adverse reaction to the vaccine. I had a sore throat and slight fever prior to test positive to COVID-19 on 03/20/2023. I contacted the doctor and got a prescription for Paxlovid that I am taking now. I am tolerating the medication without any complications. I have congestion, cough and a runny nose.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I had a sore throat and slight fever prior to test positive to COVID-19 on 03/20/2023. I contacted the doctor and got a prescription for Paxlovid that I am taking now. I am tolerating the medication without any complications. I have congestion, cough and a runny nose.
Age: 62.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Blood test normal, Blood thyroid stimulating hormone normal, Limb discomfort, Peripheral coldness, Raynaud's phenomenon
Clinical narrative: 2/3/23 I started experiencing abnormally cold feet and I could not get them to warm up. I tried different layers, wearing 3 pairs of socks to work. It was very uncomfortable. This went on for three weeks. On 2/13/23 I went to the emergency room and was diagnosed with Peripheral Neuropathy. I was prescribed gabapentin. The doctor said there was no reason given to explain why I was having this neuropathy. I went to my regular doctor on 2/17/23 and he said it was not neuropathy. I was diagnosed with Raynaud's Phenomenon. I was taken off gabapentin and was put on nifedipine. I started taking that medication the next day. I began experiencing side effects that were pretty extreme. My feet started burning and I felt very uncomfortable. I went back to my doctor a week later. He cut the dosage of nifedipine down to one a day from two a day and that seemed to help. I still had burning in my feet that felt like I was stepping on shards of glass, and they were still cold. This past week I have noticed some improvement. I had another follow up with my doctor again. He checked my vitals and was pleased with my progress; said I was doing much better. I have another appointment on May 3, 2023 with my PCP.
Age: 62.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Thyroxine free normal
Clinical narrative: 2/3/23 I started experiencing abnormally cold feet and I could not get them to warm up. I tried different layers, wearing 3 pairs of socks to work. It was very uncomfortable. This went on for three weeks. On 2/13/23 I went to the emergency room and was diagnosed with Peripheral Neuropathy. I was prescribed gabapentin. The doctor said there was no reason given to explain why I was having this neuropathy. I went to my regular doctor on 2/17/23 and he said it was not neuropathy. I was diagnosed with Raynaud's Phenomenon. I was taken off gabapentin and was put on nifedipine. I started taking that medication the next day. I began experiencing side effects that were pretty extreme. My feet started burning and I felt very uncomfortable. I went back to my doctor a week later. He cut the dosage of nifedipine down to one a day from two a day and that seemed to help. I still had burning in my feet that felt like I was stepping on shards of glass, and they were still cold. This past week I have noticed some improvement. I had another follow up with my doctor again. He checked my vitals and was pleased with my progress; said I was doing much better. I have another appointment on May 3, 2023 with my PCP.
Age: 34.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Abdominal pain upper, Computerised tomogram abdomen abnormal, Endoscopy abnormal, Epigastric discomfort
Clinical narrative: I started having stomach pains in December of 2022. I had a doctor appointment on December 15, 2022. I have had GERD since college so I thought it was a flare but it became much worse than ever before. I had a CT scan which came back normal. I was prescribed Pantoprazole. The symptoms escalated after taking the medication. My doctor referred me to a gastroenterologist in early February 2023. She recommended an upper endoscopy in early March. It showed a lot of irritation in my stomach but no masses. They said it was an idiomatic flare up and prescribed Omeprazole 40mg. It has not been helping a lot, but they did tell me it may take a while to be effective. The main symptoms have returned to about baseline. I never had stomach pain like that before.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Aphasia, COVID-19, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: 3/9/2023  PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is an 89-year-old female with past medical history of CVA with expressive aphasia, seizures, chronic atrial fibrillation, and dementia who presented with shortness of breath.  In the emergency department she was hypoxic to 87% on room air and required 3 L of oxygen via nasal cannula.  Chest x-ray showed mild pulmonary vascular distension.  Perihilar opacities were seen.  The patient was admitted to the hospitalist service and started on IV remdesivir and PO Decadron.  With these interventions in supportive care her oxygenation improved and she was weaned to room air.   The patient was noted to have acute encephalopathy on admission secondary to IV Ativan given in the emergency department.  She was at her baseline mentation the following morning.   A humerus fracture was seen on chest x-ray which had been initially diagnosed in November of 2022. I did reach out to ortho discussed these findings with them and they requested outpatient follow-up.     The patient was noted to have aphasia on SLP evaluation and was advised to continue with a mechanical soft solids and nectar after thick liquid diet.   PT/OT evaluated the patient and felt she was safe to return home with assist.  She was discharged there in stable condition.  She was advised to follow-up with her primary care provider within 5 days of discharge
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Encephalopathy, Lung opacity, Pulmonary vascular disorder
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: 3/9/2023  PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is an 89-year-old female with past medical history of CVA with expressive aphasia, seizures, chronic atrial fibrillation, and dementia who presented with shortness of breath.  In the emergency department she was hypoxic to 87% on room air and required 3 L of oxygen via nasal cannula.  Chest x-ray showed mild pulmonary vascular distension.  Perihilar opacities were seen.  The patient was admitted to the hospitalist service and started on IV remdesivir and PO Decadron.  With these interventions in supportive care her oxygenation improved and she was weaned to room air.   The patient was noted to have acute encephalopathy on admission secondary to IV Ativan given in the emergency department.  She was at her baseline mentation the following morning.   A humerus fracture was seen on chest x-ray which had been initially diagnosed in November of 2022. I did reach out to ortho discussed these findings with them and they requested outpatient follow-up.     The patient was noted to have aphasia on SLP evaluation and was advised to continue with a mechanical soft solids and nectar after thick liquid diet.   PT/OT evaluated the patient and felt she was safe to return home with assist.  She was discharged there in stable condition.  She was advised to follow-up with her primary care provider within 5 days of discharge
Age: 85.0
Sex: M
Vaccine: PNC20
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: ITCHING, RASH AND REDNESS
Age: 73.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Acute respiratory failure, Atelectasis, Bradycardia, Bronchial secretion retention, COVID-19
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 10, 2023 PRESENTING PROBLEM: Hypoxia [R09.02] Acute respiratory failure with hypoxia COVID-19   HOSPITAL COURSE:   Patient is a 73 y.o. male with a past medical history of essential tremor, chronic back pain with implanted morphine pump, non insulin-dependent type 2 diabetes and depression who presents today with cough, dyspnea and anorexia.  Symptoms started on 02/27.  The patient states that it started with a sore throat and cough.     In the ER the patient was noted to be hypoxic on room air with an SpO2 of 87%.  He remained hypoxic on nasal cannula and required non-rebreather with 15 L of oxygen.  He did receive an albuterol inhaler and 6 mg of Decadron.  He was able to be weaned down to 6 L by nasal cannula.  His other vital signs were unremarkable.  Labs significant for hemoglobin 12.7.  Procalcitonin was negative.  Viral PCR positive for COVID-19.  Chest x-ray with new mild left basilar atelectasis or pneumonitis.  CTA thorax showed mucous plugging w consolidation. Pt was started on remdsivir and decadron. 02 req improved and after 48 hrs was on 3L. On the 3rd day he was able to be weaned off 02. Labs and VS stable throughout stay. Did become bradycardic in the 30's, believe it was due to remdesivir and this was discontinued. Stable for discharge on 3/10. Discharged with decadron to finish 10 day course.
Age: 73.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Chest X-ray abnormal, Computerised tomogram thorax abnormal, Cough, Decreased appetite, Dyspnoea
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 10, 2023 PRESENTING PROBLEM: Hypoxia [R09.02] Acute respiratory failure with hypoxia COVID-19   HOSPITAL COURSE:   Patient is a 73 y.o. male with a past medical history of essential tremor, chronic back pain with implanted morphine pump, non insulin-dependent type 2 diabetes and depression who presents today with cough, dyspnea and anorexia.  Symptoms started on 02/27.  The patient states that it started with a sore throat and cough.     In the ER the patient was noted to be hypoxic on room air with an SpO2 of 87%.  He remained hypoxic on nasal cannula and required non-rebreather with 15 L of oxygen.  He did receive an albuterol inhaler and 6 mg of Decadron.  He was able to be weaned down to 6 L by nasal cannula.  His other vital signs were unremarkable.  Labs significant for hemoglobin 12.7.  Procalcitonin was negative.  Viral PCR positive for COVID-19.  Chest x-ray with new mild left basilar atelectasis or pneumonitis.  CTA thorax showed mucous plugging w consolidation. Pt was started on remdsivir and decadron. 02 req improved and after 48 hrs was on 3L. On the 3rd day he was able to be weaned off 02. Labs and VS stable throughout stay. Did become bradycardic in the 30's, believe it was due to remdesivir and this was discontinued. Stable for discharge on 3/10. Discharged with decadron to finish 10 day course.
Age: 73.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Haemoglobin decreased, Lung consolidation, Oropharyngeal pain, Pneumonitis, Procalcitonin normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 10, 2023 PRESENTING PROBLEM: Hypoxia [R09.02] Acute respiratory failure with hypoxia COVID-19   HOSPITAL COURSE:   Patient is a 73 y.o. male with a past medical history of essential tremor, chronic back pain with implanted morphine pump, non insulin-dependent type 2 diabetes and depression who presents today with cough, dyspnea and anorexia.  Symptoms started on 02/27.  The patient states that it started with a sore throat and cough.     In the ER the patient was noted to be hypoxic on room air with an SpO2 of 87%.  He remained hypoxic on nasal cannula and required non-rebreather with 15 L of oxygen.  He did receive an albuterol inhaler and 6 mg of Decadron.  He was able to be weaned down to 6 L by nasal cannula.  His other vital signs were unremarkable.  Labs significant for hemoglobin 12.7.  Procalcitonin was negative.  Viral PCR positive for COVID-19.  Chest x-ray with new mild left basilar atelectasis or pneumonitis.  CTA thorax showed mucous plugging w consolidation. Pt was started on remdsivir and decadron. 02 req improved and after 48 hrs was on 3L. On the 3rd day he was able to be weaned off 02. Labs and VS stable throughout stay. Did become bradycardic in the 30's, believe it was due to remdesivir and this was discontinued. Stable for discharge on 3/10. Discharged with decadron to finish 10 day course.
Age: 73.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 10, 2023 PRESENTING PROBLEM: Hypoxia [R09.02] Acute respiratory failure with hypoxia COVID-19   HOSPITAL COURSE:   Patient is a 73 y.o. male with a past medical history of essential tremor, chronic back pain with implanted morphine pump, non insulin-dependent type 2 diabetes and depression who presents today with cough, dyspnea and anorexia.  Symptoms started on 02/27.  The patient states that it started with a sore throat and cough.     In the ER the patient was noted to be hypoxic on room air with an SpO2 of 87%.  He remained hypoxic on nasal cannula and required non-rebreather with 15 L of oxygen.  He did receive an albuterol inhaler and 6 mg of Decadron.  He was able to be weaned down to 6 L by nasal cannula.  His other vital signs were unremarkable.  Labs significant for hemoglobin 12.7.  Procalcitonin was negative.  Viral PCR positive for COVID-19.  Chest x-ray with new mild left basilar atelectasis or pneumonitis.  CTA thorax showed mucous plugging w consolidation. Pt was started on remdsivir and decadron. 02 req improved and after 48 hrs was on 3L. On the 3rd day he was able to be weaned off 02. Labs and VS stable throughout stay. Did become bradycardic in the 30's, believe it was due to remdesivir and this was discontinued. Stable for discharge on 3/10. Discharged with decadron to finish 10 day course.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: 3RD DOSE COVID VACCINE GIVEN 10/4/21, PFIZER, #FE3590;  pt had a positive COVID test on 10/1/22 at home; family requested a welfare check; police to pt's house where he was found unresponsive; deceased;
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, COVID-19, Chills, Fatigue, Pain
Clinical narrative: I did not have an adverse reaction to the vaccine. For a couple of days prior to testing positive for COVID-19 I had congestion. On 03/16/2023, I had severe chills and fever. I tested positive for COVID-19 on 03/17/2023. I contacted my doctor and got a prescription for Paxlovid. I lost my sense of taste, body aches and fatigue. I tolerated the medication without any issues. As of today, I still have congestion and tired or washed out.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. For a couple of days prior to testing positive for COVID-19 I had congestion. On 03/16/2023, I had severe chills and fever. I tested positive for COVID-19 on 03/17/2023. I contacted my doctor and got a prescription for Paxlovid. I lost my sense of taste, body aches and fatigue. I tolerated the medication without any issues. As of today, I still have congestion and tired or washed out.
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angiogram pulmonary abnormal, Asthenia, Blood electrolytes abnormal, Blood magnesium decreased, Blood phosphorus decreased
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 11, 2023 PRESENTING PROBLEM: Hypoxemia Hypokalemia Weakness History of fall COVID-19   HOSPITAL COURSE: Patient is a 85 y.o. female with history of dementia, stage 3a CKD, hypothyroidism, hypertension, depression with anxiety and vitamin D deficiency who resides in Assisted Living Facility.  She was diagnosed with COVID-19 on 03/02 and had progressively worsening weakness and fall prompting ER visit. On presentation, she was hypoxemic and hypothermic.  D-dimer was elevated, CTA thorax was obtained and showed no PE, but did exhibit patchy and confluent areas of consolidation in the left lower lobe.  Both CT head and CT cervical spine were negative for acute pathology.  She had mild leukocytosis and procalcitonin was notably elevated at 2.19.  She was started on Decadron, remdesivir for COVID and IV Rocephin/doxycycline for suspected superimposed bacterial pneumonia.  Over the next 2 days patient was weaned to room air and respiratory symptoms improved.  Patient also had low potassium, magnesium, and phosphorus.  Electrolytes replaced and WNL at time of discharge.  PT/OT did recommend SAR, however placement would be delayed until 3/13 COVID isolation status.  The patient did have hospital delirium in the setting of dementia and acute infection.  Family preferred that the patient returned back to her home Assisted Living Facility. Care management was able to arrange for patient to have PT/OT 5 days per week and 24hr assistance with family.  Patient subsequently discharged back to Assisted Living Facility and stable condition.  She completed 4 days of IV antibiotics and was transition to PO Ceftin at discharge to complete total 5 day course.  Decadron and remdesivir stopped at discharge.
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood potassium decreased, COVID-19, Computerised tomogram head normal, Computerised tomogram spine normal, Delirium
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 11, 2023 PRESENTING PROBLEM: Hypoxemia Hypokalemia Weakness History of fall COVID-19   HOSPITAL COURSE: Patient is a 85 y.o. female with history of dementia, stage 3a CKD, hypothyroidism, hypertension, depression with anxiety and vitamin D deficiency who resides in Assisted Living Facility.  She was diagnosed with COVID-19 on 03/02 and had progressively worsening weakness and fall prompting ER visit. On presentation, she was hypoxemic and hypothermic.  D-dimer was elevated, CTA thorax was obtained and showed no PE, but did exhibit patchy and confluent areas of consolidation in the left lower lobe.  Both CT head and CT cervical spine were negative for acute pathology.  She had mild leukocytosis and procalcitonin was notably elevated at 2.19.  She was started on Decadron, remdesivir for COVID and IV Rocephin/doxycycline for suspected superimposed bacterial pneumonia.  Over the next 2 days patient was weaned to room air and respiratory symptoms improved.  Patient also had low potassium, magnesium, and phosphorus.  Electrolytes replaced and WNL at time of discharge.  PT/OT did recommend SAR, however placement would be delayed until 3/13 COVID isolation status.  The patient did have hospital delirium in the setting of dementia and acute infection.  Family preferred that the patient returned back to her home Assisted Living Facility. Care management was able to arrange for patient to have PT/OT 5 days per week and 24hr assistance with family.  Patient subsequently discharged back to Assisted Living Facility and stable condition.  She completed 4 days of IV antibiotics and was transition to PO Ceftin at discharge to complete total 5 day course.  Decadron and remdesivir stopped at discharge.
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Electrolyte substitution therapy, Fall, Fibrin D dimer increased, Hypokalaemia, Hypothermia
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 11, 2023 PRESENTING PROBLEM: Hypoxemia Hypokalemia Weakness History of fall COVID-19   HOSPITAL COURSE: Patient is a 85 y.o. female with history of dementia, stage 3a CKD, hypothyroidism, hypertension, depression with anxiety and vitamin D deficiency who resides in Assisted Living Facility.  She was diagnosed with COVID-19 on 03/02 and had progressively worsening weakness and fall prompting ER visit. On presentation, she was hypoxemic and hypothermic.  D-dimer was elevated, CTA thorax was obtained and showed no PE, but did exhibit patchy and confluent areas of consolidation in the left lower lobe.  Both CT head and CT cervical spine were negative for acute pathology.  She had mild leukocytosis and procalcitonin was notably elevated at 2.19.  She was started on Decadron, remdesivir for COVID and IV Rocephin/doxycycline for suspected superimposed bacterial pneumonia.  Over the next 2 days patient was weaned to room air and respiratory symptoms improved.  Patient also had low potassium, magnesium, and phosphorus.  Electrolytes replaced and WNL at time of discharge.  PT/OT did recommend SAR, however placement would be delayed until 3/13 COVID isolation status.  The patient did have hospital delirium in the setting of dementia and acute infection.  Family preferred that the patient returned back to her home Assisted Living Facility. Care management was able to arrange for patient to have PT/OT 5 days per week and 24hr assistance with family.  Patient subsequently discharged back to Assisted Living Facility and stable condition.  She completed 4 days of IV antibiotics and was transition to PO Ceftin at discharge to complete total 5 day course.  Decadron and remdesivir stopped at discharge.
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia, Leukocytosis, Lung consolidation, Pneumonia bacterial, Procalcitonin increased
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 11, 2023 PRESENTING PROBLEM: Hypoxemia Hypokalemia Weakness History of fall COVID-19   HOSPITAL COURSE: Patient is a 85 y.o. female with history of dementia, stage 3a CKD, hypothyroidism, hypertension, depression with anxiety and vitamin D deficiency who resides in Assisted Living Facility.  She was diagnosed with COVID-19 on 03/02 and had progressively worsening weakness and fall prompting ER visit. On presentation, she was hypoxemic and hypothermic.  D-dimer was elevated, CTA thorax was obtained and showed no PE, but did exhibit patchy and confluent areas of consolidation in the left lower lobe.  Both CT head and CT cervical spine were negative for acute pathology.  She had mild leukocytosis and procalcitonin was notably elevated at 2.19.  She was started on Decadron, remdesivir for COVID and IV Rocephin/doxycycline for suspected superimposed bacterial pneumonia.  Over the next 2 days patient was weaned to room air and respiratory symptoms improved.  Patient also had low potassium, magnesium, and phosphorus.  Electrolytes replaced and WNL at time of discharge.  PT/OT did recommend SAR, however placement would be delayed until 3/13 COVID isolation status.  The patient did have hospital delirium in the setting of dementia and acute infection.  Family preferred that the patient returned back to her home Assisted Living Facility. Care management was able to arrange for patient to have PT/OT 5 days per week and 24hr assistance with family.  Patient subsequently discharged back to Assisted Living Facility and stable condition.  She completed 4 days of IV antibiotics and was transition to PO Ceftin at discharge to complete total 5 day course.  Decadron and remdesivir stopped at discharge.
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Superinfection
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 11, 2023 PRESENTING PROBLEM: Hypoxemia Hypokalemia Weakness History of fall COVID-19   HOSPITAL COURSE: Patient is a 85 y.o. female with history of dementia, stage 3a CKD, hypothyroidism, hypertension, depression with anxiety and vitamin D deficiency who resides in Assisted Living Facility.  She was diagnosed with COVID-19 on 03/02 and had progressively worsening weakness and fall prompting ER visit. On presentation, she was hypoxemic and hypothermic.  D-dimer was elevated, CTA thorax was obtained and showed no PE, but did exhibit patchy and confluent areas of consolidation in the left lower lobe.  Both CT head and CT cervical spine were negative for acute pathology.  She had mild leukocytosis and procalcitonin was notably elevated at 2.19.  She was started on Decadron, remdesivir for COVID and IV Rocephin/doxycycline for suspected superimposed bacterial pneumonia.  Over the next 2 days patient was weaned to room air and respiratory symptoms improved.  Patient also had low potassium, magnesium, and phosphorus.  Electrolytes replaced and WNL at time of discharge.  PT/OT did recommend SAR, however placement would be delayed until 3/13 COVID isolation status.  The patient did have hospital delirium in the setting of dementia and acute infection.  Family preferred that the patient returned back to her home Assisted Living Facility. Care management was able to arrange for patient to have PT/OT 5 days per week and 24hr assistance with family.  Patient subsequently discharged back to Assisted Living Facility and stable condition.  She completed 4 days of IV antibiotics and was transition to PO Ceftin at discharge to complete total 5 day course.  Decadron and remdesivir stopped at discharge.
Sex: U
Vaccine: HEPA, MEN, TTOX
Symptoms: Condition aggravated, Relapsing-remitting multiple sclerosis, Sensory disturbance, Spinal disorder, Therapy non-responder
Clinical narrative: Probable meningococcal, Hepatitis A, and tetanus vaccine unmasking of  Relapsing-remitting multiple sclerosis (RRMS); Literature Report: This literature marketed report has been received from the authors of the published literature article entitled as above regarding a late 40's patient of unknown gender, who was part of a study that evaluate the prevalence and clinical characteristics iatrogenic central nervous system (CNS) inflammatory events of a total of 27 patients in a tertiary neuroimmunology clinic over five years from January 2017 and December 2021. The patient's pertinent medical history included autoimmune Grave's disease; previous drug reactions or allergies and concomitant medications were not provided. The patient did not have any cancer history.  On an unknown date, the patient was vaccinated with meningococcal, Hepatitis A, and tetanus vaccine (manufacturers unknown) (doses, vaccine schemes, routes, lot numbers and expiration dates were not provided).   After 7 days of the last dose of the vaccines, the patient experienced probable meningococcal, Hepatitis A, and tetanus vaccine unmasking relapsing-remitting multiple sclerosis (RRMS) with spinal sensory attack. The Naranjo Adverse Drug Reaction Probability Scale result was 7 and was used to score the probability of iatrogenicity.  Treatment with intravenous methylprednisolone (IVMP) was given with "none" response. The final disease course was reported as RR (prior spinal CIS). The outcome of the event was not provided.  The causality assessment between the event and the suspect vaccines was considered to be related.  Upon internal review, the event relapsing-remitting multiple sclerosis (RRMS) was determined to be medically significant.   A copy of the published article is attached as further documentation of the patient's experience.  This is one of several reports derived from the same literature article.; Sender's Comments:  US-009507513-2303USA007194:MSD
Sex: U
Vaccine: HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No additional AE; patient received only 2 of 3 doses in 2017. Nurse called in today because she learned of administration of third/final dose of GARDASIL 9 on 3/20/2023.; This spontaneous report as received from an other health professional refers to a patient of unknown age and gender. No information on patient medical history, current condition and concomitant medication was provided.  In 2017, patient was vaccinated with first and second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). On 20-MAR-2023 the patient was vaccinated with third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (exact dose, route of administration, lot# and expiration date were not provided) (inappropriate schedule of product administration and no adverse event).
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No additional AE reported; Patient who was previously 'unvaccinated' and who was 'meant to get' separate MMRII Vaccine and separate VARIVAX Vaccine was instead administered STERILE DILUENT Reconstituted PROQUAD; This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  The patient was meant to get vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (strength, lot #, expiry date, and route of administration were not provided) and varicella virus vaccine live (oka/merck) (VARIVAX) (strength, lot #, expiry date, and route of administration were not provided), but on 13-MAR-2023, the patient was instead vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection (lot #W028565, expiration date: 06-MAR-2024) reconstituted with sterile diluent (strength, and route of administration were not provided) for prophylaxis (Wrong product administered). No additional adverse events (AEs) were reported.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac arrest, Cerebrovascular disorder, Death
Clinical narrative: 3RD DOSE COVID VACCINE GIVEN 11/20/21, MODERNA, #058F21A;  pt passed away at home; DC COD:  probably cardiac arrest, COVID, Cerebrovascular disease
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal pain upper, Colonoscopy abnormal, Computerised tomogram, Condition aggravated, Constipation
Clinical narrative: Started having cramping stomach aches a week after vaccine. A week later went to my Gastroenterologist, he thought it was just my IBSC acting up but decided to do testing. Had a Colonoscopy and CT Scan. Colonoscopy show a Polyp and doctor removed it. Doctor gave me a prescription for hyoscyamine sulfate. Medication didn't help. Had gotten extremely constipated, doctor increased dosage of LINZESS, but it didn't help either. Tried to reduce my gluten and it helped with my constipation but I still had a lot of cramping. Saw doctor again but hasn't found any diagnosis.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Irritable bowel syndrome, Large intestine polyp, Polypectomy
Clinical narrative: Started having cramping stomach aches a week after vaccine. A week later went to my Gastroenterologist, he thought it was just my IBSC acting up but decided to do testing. Had a Colonoscopy and CT Scan. Colonoscopy show a Polyp and doctor removed it. Doctor gave me a prescription for hyoscyamine sulfate. Medication didn't help. Had gotten extremely constipated, doctor increased dosage of LINZESS, but it didn't help either. Tried to reduce my gluten and it helped with my constipation but I still had a lot of cramping. Saw doctor again but hasn't found any diagnosis.
Age: 72.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Bell's palsy, Laboratory test
Clinical narrative: I went to the emergency room and the doctor ran tests on me to make sure I wasn't having a stroke and it ended up being Bell's Palsy.
Age: 54.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, Sinusitis
Clinical narrative: I had a cold that I contracted on 08MAR2023 as it was resolving I started to get a sinus infection 13MAR2023 that has lasted a couple weeks now and continuing.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Oropharyngeal pain, Pyrexia, Vaccine breakthrough infection
Clinical narrative: I had a breakthrough case of Covid-19 with an intense cough sore throat and fever.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Depressed mood, Malaise, Nausea
Clinical narrative: My symptoms were sore throat, coughing, nausea. I tested positive for COVID-19 on 01/03/2023. I called my provider on 01/04/2023 and provider prescribed medication but did not take medication. I was sick for 10 days and tested negative for COVID-19 on 01/13/2023.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: My symptoms were sore throat, coughing, nausea. I tested positive for COVID-19 on 01/03/2023. I called my provider on 01/04/2023 and provider prescribed medication but did not take medication. I was sick for 10 days and tested negative for COVID-19 on 01/13/2023.
Age: 78.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Fatigue, Nasopharyngitis, Oropharyngeal pain, Pain
Clinical narrative: Woke up with a mild sore throat.  Next day it was a raging sore throat, with fatigue and body aches.  Did not have a fever.  3/2 went to Urgent care.  Tested positive for COVID-19 on a rapid test.  Tested for Strep Throat, negative.  Doctor proscribed Paxlovid.  Symptoms improved after 3 days, did not notice any effect of Paxlovid for the first couple of days.  Symptoms disappeared after 5 days.  Rebound of symptoms on day 8.  Rebound symptoms were much milder, Sore throat, head and chest congestion.  These symptoms lasted another 5 days, but cough, fatigue and a little bit of a head cold linger to time of reporting.
Age: 78.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Streptococcus test negative
Clinical narrative: Woke up with a mild sore throat.  Next day it was a raging sore throat, with fatigue and body aches.  Did not have a fever.  3/2 went to Urgent care.  Tested positive for COVID-19 on a rapid test.  Tested for Strep Throat, negative.  Doctor proscribed Paxlovid.  Symptoms improved after 3 days, did not notice any effect of Paxlovid for the first couple of days.  Symptoms disappeared after 5 days.  Rebound of symptoms on day 8.  Rebound symptoms were much milder, Sore throat, head and chest congestion.  These symptoms lasted another 5 days, but cough, fatigue and a little bit of a head cold linger to time of reporting.
Age: 50.0
Sex: F
Vaccine: FLU4
Symptoms: Hypersensitivity, Peripheral swelling, Pruritus
Clinical narrative: Patient reported having an allergic reaction to flu vaccine in the past. Symptoms included swelling and itching in the arm the vaccine was  injected. Patient given Benadryl for similar symptoms. Patient was observed for 30 minutes with no signs of airway or circulation issues. Patient is to report to her Primary Care Physician for any other issues.
Age: 62.0
Sex: F
Vaccine: COVID19, TDAP
Symptoms: Balance disorder, COVID-19, Dizziness, Magnetic resonance imaging head abnormal, Musculoskeletal stiffness
Clinical narrative: I already had some tremors in one of my legs, and I developed COVID19 after my 3rd COVID19 vaccination, it was pretty mild. Then I started to have leg tremors in both legs over the summer, in July 2022. I also experienced some toe pain in both feet, the third and forth toes. I started to get some muscle stiffness and lightheadedness. I'm an avid skier and I noticed in the fall that I was no longer able to balance correctly which was alarming. The lightheadedness started to get worse as well. In January 2023 I finally went to the doctor, and they gave me a referral to a neurologist. I had an MRI last month and it was determined that I had Parkinson's. I have started taking medication, the last day of February. I tried skiing about a week ago since the medication and was finally able to balance on my skis.
Age: 62.0
Sex: F
Vaccine: COVID19, TDAP
Symptoms: Pain in extremity, Parkinson's disease, Reflex test, Tremor
Clinical narrative: I already had some tremors in one of my legs, and I developed COVID19 after my 3rd COVID19 vaccination, it was pretty mild. Then I started to have leg tremors in both legs over the summer, in July 2022. I also experienced some toe pain in both feet, the third and forth toes. I started to get some muscle stiffness and lightheadedness. I'm an avid skier and I noticed in the fall that I was no longer able to balance correctly which was alarming. The lightheadedness started to get worse as well. In January 2023 I finally went to the doctor, and they gave me a referral to a neurologist. I had an MRI last month and it was determined that I had Parkinson's. I have started taking medication, the last day of February. I tried skiing about a week ago since the medication and was finally able to balance on my skis.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood pressure increased, Blood test normal, Blood thyroid stimulating hormone normal, Electrocardiogram ambulatory abnormal, Electrocardiogram normal
Clinical narrative: I had heart palpitations that woke me up, I had a pulse of 180 my blood pressure was 164/90. I had my husband take me to the emergency room so that we could have the test run to rule out a heart attack. Once there they hooked me up to an EKG, bloodwork, Thyroid TSH test, all tests came back negative. They sent me home and told me to follow up with my physician. I went to see my cardiologist who had me wear a Holter monitor for seven days. The monitor showed one palpitation on a Tuesday during the night, but it did not last as long as the one I went to the hospital for. I was not prescribed any medication. I feel like I am getting back to normal.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Heart rate increased, Middle insomnia, Palpitations
Clinical narrative: I had heart palpitations that woke me up, I had a pulse of 180 my blood pressure was 164/90. I had my husband take me to the emergency room so that we could have the test run to rule out a heart attack. Once there they hooked me up to an EKG, bloodwork, Thyroid TSH test, all tests came back negative. They sent me home and told me to follow up with my physician. I went to see my cardiologist who had me wear a Holter monitor for seven days. The monitor showed one palpitation on a Tuesday during the night, but it did not last as long as the one I went to the hospital for. I was not prescribed any medication. I feel like I am getting back to normal.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tinnitus
Clinical narrative: A mechanical sound in my left ear, that comes and goes. I wear a hearing aid and I thought it was a problem with my hearing aid but the sound is there when I take the it out. The doctor looked inside for a foreign body due to filters in the hearing aid, they also drained my ear and nothing came out. I will be going to see the ENT clinic next Friday.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Malaise, Nasopharyngitis, Pain
Clinical narrative: I started having symptoms on Feb 8th, bad head cold, low grade fever and body aches. It was about two weeks before I got help because I started to improve and then it got worse. I was starting to cough more so I saw a doctor. I did a home test which was positive, and I was told to treat the symptoms with over-the-counter medication. I was improving and then two days ago (03/22/2023) I started to feel sick again. I plan on testing myself again to see if I am positive for COVID-19 again.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I started having symptoms on Feb 8th, bad head cold, low grade fever and body aches. It was about two weeks before I got help because I started to improve and then it got worse. I was starting to cough more so I saw a doctor. I did a home test which was positive, and I was told to treat the symptoms with over-the-counter medication. I was improving and then two days ago (03/22/2023) I started to feel sick again. I plan on testing myself again to see if I am positive for COVID-19 again.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Headache, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Had a fever and headache, took a home COVID-19 test and was positive. Contacted doctor and was prescribed Remdesivir. Took full course of medication and started feeling better. Still have a small cough.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Patient had a breakthrough infection and expired.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anaemia of chronic disease, Asthenia, Blood creatinine increased, COVID-19
Clinical narrative: Admit date: 3/7/2023   Expected discharge date and time: 3/17/2023 ?   Admitting Physician:  MD Discharge Clinician:  MD PRESENTING PROBLEM: Acute renal failure (ARF) [N17.9] AKI (acute kidney injury) [N17.9] Anemia in other chronic diseases classified elsewhere [D63.8] COVID [U07.1]   Hospital Course:  85-year-old with past medical history significant for CLL, CKD5, B-cell lymphoma, hyperlipidemia, DM 2, cardiomyopathy who was admitted to facility on 03/07/2023 for symptoms of weakness, cough, cold, nausea.  Was noted to be in AKI CKD 5 with a creatinine of 7.86 (baseline between 4.3-5.3).  Was positive for COVID-19 r.  Chest x-ray showed peripheral vascular congestion without pneumonia.  Patient was admitted to internal medicine with Nephrology on consult.   Post admission patient was started on gentle IV fluids.  Nephrology was consulted.  Hemodialysis was offered to the patient but she refused.  Currently on gentle IV fluids driven by Nephrology.   Patient continued to remain on room air.  However given severe symptoms Started on Decadron 6 mg orally daily.  Was not a candidate for remdesivir with her AKI.   Hospice was offered to the patient which she refused initially.  Palliative following along for goals of care discussion.     Ultimately patient's renal function continued to worsen.  Patient was treated for tracheobronchitis as well.  Patient was treated with IV fluids for renal failure worsening chronic kidney disease.  Patient admitted to Facility 3/7/23 to 3/17/23 for AKI and Anemia.  Patient transitioned to comfort and care and passed on 3/18.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Condition aggravated, Cough, Death, End stage renal disease
Clinical narrative: Admit date: 3/7/2023   Expected discharge date and time: 3/17/2023 ?   Admitting Physician:  MD Discharge Clinician:  MD PRESENTING PROBLEM: Acute renal failure (ARF) [N17.9] AKI (acute kidney injury) [N17.9] Anemia in other chronic diseases classified elsewhere [D63.8] COVID [U07.1]   Hospital Course:  85-year-old with past medical history significant for CLL, CKD5, B-cell lymphoma, hyperlipidemia, DM 2, cardiomyopathy who was admitted to facility on 03/07/2023 for symptoms of weakness, cough, cold, nausea.  Was noted to be in AKI CKD 5 with a creatinine of 7.86 (baseline between 4.3-5.3).  Was positive for COVID-19 r.  Chest x-ray showed peripheral vascular congestion without pneumonia.  Patient was admitted to internal medicine with Nephrology on consult.   Post admission patient was started on gentle IV fluids.  Nephrology was consulted.  Hemodialysis was offered to the patient but she refused.  Currently on gentle IV fluids driven by Nephrology.   Patient continued to remain on room air.  However given severe symptoms Started on Decadron 6 mg orally daily.  Was not a candidate for remdesivir with her AKI.   Hospice was offered to the patient which she refused initially.  Palliative following along for goals of care discussion.     Ultimately patient's renal function continued to worsen.  Patient was treated for tracheobronchitis as well.  Patient was treated with IV fluids for renal failure worsening chronic kidney disease.  Patient admitted to Facility 3/7/23 to 3/17/23 for AKI and Anemia.  Patient transitioned to comfort and care and passed on 3/18.